Core Insights - UnitedHealth Group (UNH) shares experienced a significant decline after reporting fourth-quarter results that fell short of Wall Street expectations and provided a lackluster outlook due to rising medical costs [2][9] - The company maintained its 2025 outlook, projecting a medical cost ratio (MCR) of 86% to 87% for the current year, compared to just over 82% in Q1 2023 [2] Stock Performance - UnitedHealth shares dropped 6% to $510.59, marking a nearly 20% decrease from its record high in November, while remaining virtually unchanged year-over-year, in contrast to a 25% gain in the S&P 500 over the same period [3] - The stock faced selling pressure near the 200-day moving average, with the recent drop occurring on the highest trading volume since a previous decline [4][9] Technical Analysis - Key support levels to monitor include approximately $475, which aligns with a multi-month trendline, and $436, where investors may seek buying opportunities near the April 2024 low [6][9] - Important overhead resistance levels to watch are around $550, where profit-taking may occur, and $605, which could present selling pressure near previous peaks just below the all-time high [7][8][9]
Watch These UnitedHealth Price Levels as Stock Slumps After Disappointing Results